The Leukemia and Lymphoma Society has awarded associate professor Hilary Coller of molecular, cell and development biology, a New Idea Award, a grant program designed to identify novel research strategies with high potential for significant impact on the future of blood cancer treatments.
Coller was one of nine researchers the society honored for their innovative ideas for substantially different approaches to diagnoses and treatment of patients with blood cancers, as well as ideas that may fundamentally change our understanding of blood cancers. The goal of the awards program is to advance concepts that may eventually lead to significant improvements in the clinical outcomes, including quality of life, of patients with blood cancers. Each researcher will each receive a $100,000, one-year grant.
Coller was recognized for her research to determine the level of a protein that helps control the activity of a gene in proliferating and quiescent populations in three different B cell tumor types.
The Leukemia and Lymphoma Society is the world's largest voluntary health agency dedicated to blood cancer.
